Sucralfate
NDC 81033-149, Sucralfate, suspension, from Kesin Pharma Corporation.
- Product NDC
- 81033-149
- Status
- Listed
- Labeler
- Kesin Pharma Corporation
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216474
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81033-149 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SUCRALFATE1 g/10mL
Pharmacologic classes
Aluminum Complex [EPC]; Organometallic Compounds [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81033-149-44 | 81033014944 | 40 CUP, UNIT-DOSE in 1 CARTON (81033-149-44) / 10 mL in 1 CUP, UNIT-DOSE (81033-149-10) |
| 81033-149-52 | 81033014952 | 100 CUP, UNIT-DOSE in 1 CASE (81033-149-52) / 10 mL in 1 CUP, UNIT-DOSE (81033-149-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/36d940f2-207b-68c5-e063-6294a90a6b4a
Use it
Look up 81033-149 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81033-149 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81033-149. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.